Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Non-Interventional Study of the Treatment With Etanercept in Rheumatoid Arthritis (RA) and Ankylosing Spondylitis (AS) Subjects in Rheumatology Department

NCT01411215 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT01411215
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01411215 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Non-Interventional Study of the Treatment With Etanercept in Rheumatoid Arthritis (RA) and Ankylosing Spondylitis (AS) Subjects in Rheumatology Department
Lead sponsor
Pfizer
Phase
Observational
Overall status
Terminated
Start date
January 31, 2011
Completion date
January 31, 2013
Enrollment
160 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

ankylosing spondylitis, rheumatoid arthritis